MoneyWorks4Me

Zydus Lifesciences informs about press release

04 Jul 2023 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated July 4, 2023 titled ‘Zydus receives final approval from the USFDA for Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..